Type IV collagen (Collagen IV (ColIV or Col4))

Type IV collagen is a structural protein forming a covalently cross-linked network in basement membranes, which are specialized sheets of the extracellular matrix underlying epithelial and endothelial layers in virtually all tissues. Unlike fibrillar collagens, type IV collagen assembles into sheet-like structures through a combination of head-to-head and lateral interactions, mediated by its unique noncollagenous (NC1) domain and an absence of the regular glycine repeat, resulting in a more flexible organization. In mammals, six alpha(IV) collagen chains (encoded by COL4A1–COL4A6) are assembled into heterotrimeric protomers, which further self-associate into networks. These networks provide mechanical strength, regulate filtration (kidney glomerulus), and serve as a scaffold for cell adhesion, migration, proliferation, and differentiation. Type IV collagen is indispensable for tissue homeostasis and development, with mutations leading to hereditary diseases such as Alport syndrome, small-vessel angiopathy, and increased susceptibility to autoimmune injury (Goodpasture syndrome). It is highly insoluble and tightly crosslinked; isolation for therapeutic targeting remains challenging. Laboratory markers such as circulating fragments and genetic testing provide disease monitoring and diagnosis in relevant clinical contexts. The full name should be standardized as "Type IV collagen" if referencing the molecule itself, or "Collagen alpha-1(IV) chain" etc. for individual chains; "Collagen IV" is a common abbreviation. The molecule qualifies as a therapeutic and diagnostic target in the context of genetic, autoimmune, fibrotic, and (potentially) oncologic diseases.

Other names

Collagen IVColIVCol4type-IV collagenbasement membrane collagenalpha(IV) chains

Inhibition of collagen synthesis or deposition (anti-fibrotic agents) Disruption of collagen cross-linking or assembly (enzymatic inhibitors, experimental) Autoantibody binding leading to immune-mediated injury (e.g., Goodpasture disease) Modulation of collagen biology via receptor antagonism (experimental)